The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
Open accessAbstract
Background Recurrent malignant brain tumors (RMBTs) carry a poor prognosis. Dichloroacetate (DCA) activates mitochondrial oxidative metabolism and has shown activity against several human cancers. Design We conducted an open-label study of oral DCA in 15 adults with recurrent WHO grade III - IV gliomas or metastases from a primary cancer outside the central nervous system. The primary objective was detection of a dose limiting toxicity for RMBTs at 4 weeks of treatment, defined as any grade 4 or 5 toxicity, or grade 3 toxicity directly attributable to DCA, based on the National Cancer Institute's Common Toxicity Criteria for Adverse Events, version 4.0. Secondary objectives involved safety, tolerability and hypothesis-generating data on disease status. Dosing was based on haplotype variation in glutathione transferase zeta 1/maleylacetoacetate isomerase (GSTZ1/MAAI), which participates in DCA and tyrosine catabolism. Results Eight patients completed at least 1 four week cycle. During this time, no dose-limiting toxicities occurred. No patient withdrew because of lack of tolerance to DCA, although 2 subjects experienced grade 0-1 distal parasthesias that led to elective withdrawal and/or dose-adjustment. All subjects completing at least 1 four week cycle remained clinically stable during this time and remained on DCA for an average of 75.5 days (range 26-312). Conclusions Chronic, oral DCA is feasible and well-tolerated in patients with recurrent malignant gliomas and other tumors metastatic to the brain using the dose range established for metabolic diseases. The importance of genetic-based dosing is confirmed and should be incorporated into future trials of chronic DCA administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This knowledge has led to the testing of drugs that inhibit glycolysis such as dichloroacetic acid (DCA), which inhibits PDK activity (Dunbar et al., 2014).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dunbar et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., Mcfadden, E. T., & Carbone, P. P. (1982) · American Journal of Clinical Oncology · doi:10.1097/00000421-198212000-00014 · Cited by 11,686
A New Statistical Method for Haplotype Reconstruction from Population Data
Stephens, M., Smith, N. J. C., & Donnelly, P. (2001) · The American Journal of Human Genetics · doi:10.1086/319501 · Cited by 7,512
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J. F., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,890
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Bonnet, S., Archer, S. L., Allalunis‐Turner, J., Haromy, A., Beaulieu, C., Thompson, R. B., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S. B., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,552
Yung, W. K. A., Albright, R. E., Olson, J., Fredericks, R., Fink, K., Prados, M. D., Brada, M., Spence, A., Hohl, R. J., Shapiro, W., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1316 · Cited by 929 · cited 1×
“Recurrent malignant brain tumors (RMBTs), whether from primary malignant gliomas, or from metastasis to the central nervous system (CNS), have a poor prognosis [1, 2].”
Metabolic Modulation of Glioblastoma with Dichloroacetate
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E. B., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D. S., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 744
Research works printed but not linked: 1
- Mitchell G, Lambert M, Tanguay R. Hypertyrosinemia (1995) In Schriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, Inc., Health Professions Division, New York, pp. 1077–106
Cited by
Sorted by citations
Items 101–200 of 242
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunitiesPreprint
Shen, M., & Kang, Y. (2020) · Genes & Development · doi:10.1101/gad.343251.120 · Cited by 31
Trapella, C., Voltan, R., Melloni, E., Tisato, V., Celeghini, C., Bianco, S., Fantinati, A., Salvadori, S., Guerrini, R., Secchiero, P., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01165 · Cited by 30
Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells
de Mey, S., Dufait, I., Jiang, H., Corbet, C., Wang, H., Gucht, M. V. D., Kerkhove, L., Ka, L. L., Vandenplas, H., Gevaert, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249367 · Cited by 30
Schoonjans, C. A., Joudiou, N., Brusa, D., Corbet, C., Féron, O., & Gallez, B. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.003 · Cited by 28
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
Koltai, T., & Fliegel, L. (2024) · Pharmaceuticals · doi:10.3390/ph17060744 · Cited by 28
Ward, N. P., Poff, A. M., Koutnik, A. P., & D’Agostino, D. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180061 · Cited by 30
Savic, L. J., Chapiro, J., Duwe, G., & Geschwind, J.-F. (2015) · Hepatic Oncology · doi:10.2217/hep.15.36 · Cited by 28
Kim, E. Y., Abides, J., Keller, C. R., Martinez, S. R., & Li, W. (2025) · Molecules · doi:10.3390/molecules30081763 · Cited by 28
Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications
Li, W., Yu, C., Zhang, X., Gu, Y., He, X., Xu, R., Xu, J. F., Yu, G., & Wu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00300-8 · Cited by 28
俞明康, Yang, D., Chen, X., Yang, Y., Zhang, B., Jiang, X., Xing, L., Yang, Y., Sun, Y., & Li, N. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00427-2 · Cited by 34
The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology
Libby, C. J., McConathy, J., Darley-Usmar, V. M., & Hjelmeland, A. B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1169 · Cited by 25
Drugging ACAT1 for Cancer Therapy
García‐Bermúdez, J., & Birsoy, K. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.023 · Cited by 24
Li, T., Li, S., Feng, Y., Zeng, X., Dong, S., Li, J., Zha, L., Luo, H., Zhao, L., Liu, B., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6973636 · Cited by 27
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 23
Parczyk, J., Ruhnau, J., Pelz, C., Schilling, M., Wu, H., Piaskowski, N. N., Eickholt, B. J., Kühn, H., Danker, K., & Klein, A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08186-9 · Cited by 23
Tiersma, J. F., Evers, B., Bakker, B. M., Jalving, M., & de Jong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073745 · Cited by 23
Cencioni, C., Scagnoli, F., Spallotta, F., Nasi, S., & Illi, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044217 · Cited by 28
Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension
Fazal, S., Bisserier, M., & Hadri, L. (2021) · Cells · doi:10.3390/cells10030638 · Cited by 27
Schoonjans, C. A., Mathieu, B., Joudiou, N., Zampieri, L. X., Brusa, D., Sonveaux, P., Féron, O., & Gallez, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103308 · Cited by 22
Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development
Larrieu, C. M., Storevik, S., Guyon, J., Zottola, A. C. P., Bouchez, C. L., Derieppe, M., Tan, T. Z., Miletić, H., Lorens, J. B., Tronstad, K. J., et al. (2022) · Cancers · doi:10.3390/cancers14153769 · Cited by 21
Cunha, A., Rocha, A. C., Barbosa, F., Baião, A., Silva, P. M. A., Sarmento, B. F. C. C., & Queirós, O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102021 · Cited by 21
Actionable Metabolic Pathways in Heart Failure and Cancer—Lessons From Cancer Cell Metabolism
Karlstaedt, A., Schiffer, W. B., & Taegtmeyer, H. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00071 · Cited by 21
Tian, D. D., Bennett, S. K., Coupland, L. A., Forwood, K., Lwin, Y., Pooryousef, N., Téa, I., Truong, T. T., Neeman, T. M., Crispin, P. J., et al. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.526 · Cited by 21
Stacpoole, P. W., Shuster, J. J., Thompson, J. L. P., Prather, R. A., Lawson, L. A., Zou, B., Buchsbaum, R., & Nixon, S. J. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.11.003 · Cited by 19
Self-citationCardoso, A. M., Sousa, M., Morais, C. M., Oancea-Castillo, L., Régnier‐Vigouroux, A., Rebelo, O., Tão, H., Barbosa, M., Pedroso, M. C. D. L., & Jurado, A. S. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz099 · Cited by 19
Mitochondrial DNA Copy Number: Linking Diabetes and Cancer
Memon, A. A., Vats, S., Sundquist, J., Li, Y., & Sundquist, K. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0100 · Cited by 19
Harguindey, S., Orozco, J. D. P., Alfarouk, K. O., & Devesa, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174278 · Cited by 19
Shroads, A. L., Coats, B. S., McDonough, C. W., Langaee, T. Y., & Stacpoole, P. W. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.371 · Cited by 19
Self-citationDe, S., & Nag, S. (2023) · Reviews in Inorganic Chemistry · doi:10.1515/revic-2023-0007 · Cited by 19
Unmasking the Warburg Effect: Unleashing the Power of Enzyme Inhibitors for Cancer Therapy
Angulo-Elizari, E., Gaviria-Soteras, L., Zubiri, I., Ramos-Inza, S., Sanmartín, C., & Plano, D. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2030037 · Cited by 18
The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression
Langaee, T. Y., Zhong, G. G., Li, W., Hamadeh, I. S., Solayman, M. H. M., McDonough, C. W., Stacpoole, P. W., & James, M. O. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000129 · Cited by 18
Self-citationLactic Acidosis in Patients with Solid Cancer
Heneberg, P. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0267 · Cited by 17
Mangal, N., James, M. O., Stacpoole, P. W., & Schmidt, S. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1009 · Cited by 18
Self-citationRessa, A., Bosdriesz, E., de Ligt, J., Mainardi, S., Maddalo, G., Prahallad, A., Jager, M., de la Fonteijne, L., Fitzpatrick, M., Groten, S., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000486 · Cited by 17
Chung, J., Saad, J., Kafri, A., Rossignol, J., Verbrugge, M., & Bakke, J. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1712576 · Cited by 19
Emadi, A., Sadowska, M., Carter‐Cooper, B., Bhatnagar, V., van der Merwe, I., Levis, M. J., Sausville, E. A., & Lapidus, R. G. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.04.002 · Cited by 17
Novel therapies hijack the blood–brain barrier to eradicate glioblastoma cancer stem cells
Vengoji, R., Ponnusamy, M. P., Rachagani, S., Mahapatra, S., Batra, S. K., Shonka, N., & Macha, M. A. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy171 · Cited by 17
Long-term stabilization of metastatic melanoma with sodium dichloroacetate
Khan, A., Andrews, D., Shainhouse, J., & Blackburn, A. C. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i4.371 · Cited by 18
Beinat, C., Patel, C. B., Xie, Y., & Gambhir, S. S. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01353-2 · Cited by 16
Stakišaitis, D., Juknevičienė, M., Damanskienė, E., Valančiūtė, A., Balnytė, I., & Alonso, M. M. (2019) · Cancers · doi:10.3390/cancers11081210 · Cited by 16
[Role and Mechanism of Lactylation in Cancer].
Zhang, Q., Cao, L., & Xu, K. (2024) · PubMed Central · doi:10.3779/j.issn.1009-3419.2024.102.20 · Cited by 15
Twarock, S., Reichert, C., Bach, K., Reiners, O., Kretschmer, I., Gorski, D. J., Gorges, K., Grandoch, M., & Fischer, J. W. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14808 · Cited by 15
Targeting metabolic dependencies in pediatric cancer
Issaq, S. H., & Heske, C. M. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000853 · Cited by 15
Etiopathogenesis of oncocytomas
Correia, M., Silva-Pinheiro, P., Batısta, R., Soares, P., Sobrinho-Simões, M. A., & Máximo, V. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.014 · Cited by 16
Zhang, Y., Sun, M., Zhao, H., Wang, Z., Shi, Y., Dong, J., Wang, K., Wang, X., Li, X., Qi, H., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s439728 · Cited by 13
Active pyruvate dehydrogenase and impaired gluconeogenesis in orthotopic hepatomas of rats
Lee, M. H., DeBerardinis, R. J., Wen, X., Corbin, I. R., Sherry, A. D., Malloy, C. R., & Jin, E. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153993 · Cited by 13
Yan, J., Qi, Y., Liu, Y., Jiang, X., Li, Y., Song, Z., Zhang, L., & Zhang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115390 · Cited by 14
Metabolic adaptation of myeloid cells in the glioblastoma microenvironment
Essakhi, N., Bertucci, A., Baeza, N., Colin, C., Lavignolle, R., García-González, P. A., Argüello, R. J., Tchoghandjian, A., & Tabouret, É. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1431112 · Cited by 12
Qiu, Q., Deng, H., Song, P., Liu, Y., & Zhang, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073368 · Cited by 13
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate
Lopalco, A., Curci, A., Lopedota, A. A., Cutrignelli, A., Laquintana, V., Franco, M., & Denora, N. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.11.013 · Cited by 12
Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines
Harting, T. P., Stubbendorff, M., Hammer, S. C., Schadzek, P., Ngezahayo, A., Escobar, H. M., & Nolte, I. J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178744 · Cited by 12
Regulatory role and therapeutic prospect of lactate modification in cancer
Sun, M., Wang, K., Lu, F., Yu, D., & Liu, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1508552 · Cited by 12
Hypoxic microenvironment in cancer: role in metabolic reprogramming
Sureka, N., Maheshwari, R., Agravat, A., Singhal, S., Zaman, S., Rishi, B., Siraj, F., Zaheer, S., & Misra, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1771365 · Cited by 11
Metabolic Profiling Techniques and Their Application in Cancer Research
Alwahsh, M., Abumansour, H., Althaher, A. R., & Hergenröder, R. (2024) · Current Pharmaceutical Analysis · doi:10.2174/0115734129317614240809053901 · Cited by 11
Sánchez‐Castillo, A., Savelkouls, K. G. M., Baldini, A., Hounjet, J., Sonveaux, P., Verstraete, P., Keersmaecker, K. D., Dewaele, B., Björkblom, B., Melin, B. S., et al. (2024) · Oncogenesis · doi:10.1038/s41389-024-00540-3 · Cited by 11
Non-coding RNAs: emerging regulators of glucose metabolism in hepatocellular carcinoma.
Lai, Y., Huang, H., Abudoureyimu, M., Lin, X., Tian, C., Wang, T., Chu, X., & Wang, R. (2020) · PubMed Central · Cited by 11
Deng, J., Wang, D., Jiang, K., Lang, X., Sun, Y., & Li, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.08.017 · Cited by 11
Advances in the therapeutic applications of dichloroacetate as a metabolic regulator: A review
Wu, X., Shang, M., Li, M., Liu, Y., Hu, H. H., Zhang, P., He, Q., & Lin, S. (2025) · Medicine · doi:10.1097/md.0000000000044295 · Cited by 10
Stanevičiūtė, J., Juknevičienė, M., Palubinskienė, J., Balnytė, I., Valančiūtė, A., Vosyliūtė, R., Sužiedėlis, K., Lesauskaitė, V., & Stakišaitis, D. (2018) · Dose-Response · doi:10.1177/1559325818811522 · Cited by 10
PP2A ‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells
Denisova, O. V., Merisaari, J., Huhtaniemi, R., Qiao, X., Yetukuri, L., Jumppanen, M., Kaur, A., Pääkkönen, M., von Schantz‐Fant, С., Ohlmeyer, M. H. J., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13488 · Cited by 12
Therapy for Chronic Myelomonocytic Leukemia in a New Era
Moyo, T. K., & Savona, M. R. (2017) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-017-0408-8 · Cited by 10
Mitocans: Mitochondrially Targeted Anti-cancer Drugs
Boukalová, Š., Rohlenová, K., Rohlena, J., & Neužil, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_27 · Cited by 12
The changing landscape of clinical trials for mitochondrial diseases: 2011 to present
Khayat, D., Kurtz, T. L., & Stacpoole, P. W. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.10.010 · Cited by 10
Self-citationMulti-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models
Neveu, M.-A. C., Preter, G. D., Joudiou, N., Bol, A., Brender, J., Saito, K., Kishimoto, S., Grégoire, V., Jordan, B. F., Krishna, M. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13176 · Cited by 9
Cytotoxic derivatives of dichloroacetic acid and some metal complexes
Hossain, M., Roth, S., Dimmock, J. R., & Das, U. (2022) · Archiv der Pharmazie · doi:10.1002/ardp.202200236 · Cited by 9
Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping Assay
Langaee, T. Y., Wagner, R., Horne, L. P., Lawson, L. A., Becker, C., Shahin, M. H., Starostik, P., & Stacpoole, P. W. (2018) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2017.0261 · Cited by 9
Self-citationSmall molecules targeting mitochondria as an innovative approach to cancer therapy
Kamble, O., Chatterjee, R., Abishek, K. G., Chandra, J., Alsayari, A., Wahab, S., Sahebkar, A., Kesharwani, P., & Dandela, R. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111396 · Cited by 8
Clinical physiology and pharmacology of GSTZ1/MAAI
Stacpoole, P. W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115818 · Cited by 8
Self-citationRan, T., Shen, Y., Peng, D., Tang, L., Pan, Z., Zeng, X., & Liu, H. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1713583 · Cited by 8
Heydari, F., Zendehdel, H., Varkiani, M. M., Fahmi, S., Derakhshani, M., Anvari, S., Farhid, F., Hamblin, M. R., & Naghinezhad, J. (2026) · Biomarker Research · doi:10.1186/s40364-026-00957-5 · Cited by 7
Lajin, B., Braeuer, S., Borovička, J., & Goessler, W. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130819 · Cited by 6
Unlocking the Role of Metabolic Pathways in Brain Metastatic Disease
Pinto, M., Violante, S. N., Cascão, R., & Faria, C. C. (2025) · Cells · doi:10.3390/cells14100707 · Cited by 5
Denisova, O. V., Merisaari, J., Kaur, A., Yetukuri, L., Jumppanen, M., von Schantz, C., Ohlmeyer, M. H. J., Wennerberg, K., Aittokallio, T. A., Taipale, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18118-7 · Cited by 4
Marco-Brualla, J., de Miguel, D., Martínez‐Lostao, L., & Anel, A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020608 · Cited by 5
Smeltz, M. G., Hu, Z., Zhong, G. G., Jahn, S. C., Rowland‐Faux, L., Horne, L. P., Stacpoole, P. W., & James, M. O. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00207 · Cited by 5
Self-citationExploiting metabolic dependencies for therapeutic targeting of brain cancers
Martell, E., Kuzmychova, H., Grewal, A., Chawla, U., Jain, C., Anderson, C. M., & Sharif, T. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218426 · Cited by 4
Martell, E., Kuzmychova, H., Chawla, U., Grewal, A., Jain, C., Venugopal, C., Anderson, C. M., Singh, S. K., & Sharif, T. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08646-9 · Cited by 4
Ayat, M. (2018) · American Journal of Cancer Prevention · doi:10.12691/ajcp-6-1-2 · Cited by 4
PDK2: An Underappreciated Regulator of Liver Metabolism
Woolbright, B. L., & Harris, R. A. (2021) · Livers · doi:10.3390/livers1020008 · Cited by 4
Baber, M. A., Gough, M. D., Yeomans, L., Giesler, K. E., Muzzarelli, K. M., Chen, C., Assar, Z., & Toogood, P. L. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117210 · Cited by 4
Glucose Metabolism and Carcinogenesis: The Impact of the Tumor Suppressor p53
Ntwasa, M. M., & Njende, U. (2018) · InTech eBooks · doi:10.5772/intechopen.75976 · Cited by 5
Targeting metabolic mechanisms to overcome temozolomide resistance in glioblastoma
Yan, C., Ge, Y., Hu, Z., & Ma, W. (2026) · Discover Oncology · doi:10.1007/s12672-026-04572-6 · Cited by 3
Long, Y., Xu, J., Xu, Z., Su, Z., Li, W., & Li, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119692 · Cited by 3
The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?
Ronghe, R., & Tavares, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1481241 · Cited by 4
Wang, X., Rong, C., Leng, W., Niu, P., He, Z., Wang, G., Qi, X., Zhao, D., & Li, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02399-5 · Cited by 3
Effect of sodium dichloroacetate on apoptotic gene expression in human leukemia cell lines
Abramek, J., Bogucki, J., Ziaja‐Sołtys, M., Stępniewski, A., & Bogucka‐Kocka, A. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.12.003 · Cited by 3
Cancer metabolism regulation by phytonutrients
Riaz, A., Zara, R., Bushra, G., Kanwal, N., Sadiqa, A., Shareef, F., Sarfraz, I., Shah, M. A., Uçak, İ., Bukhari, S. A., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824356-5.00002-3 · Cited by 3
Targeting tumor glycolysis metabolism in oral squamous cell carcinoma cells by brusatol
Zhang, G., Wu, Y., Chen, S., Su, Y., Yin, P., Fu, J., & Zhang, X. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100172 · Cited by 3
Carswell, G. K., Chamberlin, J., Bennett, B. D., Bushel, P. R., & Chorley, B. N. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1389634 · Cited by 3
Synthesis of Covalent Conjugates of Dichloroacetic Acid with Polyfunctional Compounds
Bazanov, D. R., Maximova, N. A., Seliverstov, M. Y., Зефиров, Н. А., Sosonyuk, S. E., & Lozinskaya, N. A. (2021) · Russian Journal of Organic Chemistry · doi:10.1134/s107042802111004x · Cited by 3
Synthesis and biotesting of new carrier prodrugs of 2-methoxyestradiol
Lozinskaya, N. A., Maximova, N. A., Bazanov, D. R., Sosonyuk, S. E., Wobith, B., Зефиров, Н. А., Харитонашвили, Е. В., Zefirova, O. N., Kuznetsov, S. A., & Proskurnina, M. V. (2020) · Mendeleev Communications · doi:10.1016/j.mencom.2020.01.002 · Cited by 3
Pyruvate Dehydrogenase Complex Deficiency: A Review of Treatments and Case Series
Betesh-Abay, B., Shany, E., Staretz‐Chacham, O., Shelef, I., & Azab, A. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062732 · Cited by 3
The Role of Lactate in Cancer Immunotherapy: Mechanisms and Applications
Fan, Y., Jia, H., & Zhang, W. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096373625250701095509 · Cited by 2
Metabolic Enzymes: New Targets for the Design of Antitumor Drugs
Braun, L., Varpetyan, E. E., Zav’yalov, G. A., Kulikov, F. V., Мариевский, В. Е., Tyul’ganova, D. A., Shishnenko, A. O., Степанова, Д. С., & Шимановский, Н. Л. (2020) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-020-02238-3 · Cited by 2
Denisova, O. V., Merisaari, J., Huhtaniemi, R., Qiao, X., Kaur, A., Yetukuri, L., Jumppanen, M., Pääkkönen, M., von Schantz‐Fant, С., Ohlmeyer, M. H. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.31.494146 · Cited by 2
Zhou, Z., Wang, L., Yan, S., Liu, Z., Sun, R., Yuan, Q., & Akkaya, E. U. (2024) · ChemPhotoChem · doi:10.1002/cptc.202400096 · Cited by 1
Carcinogenesis: An Alternative Hypothesis Comparing Mutagenic Versus Metabolic Models
Alhatem, A., Gagna, C. E., Lambert, M. W., Keenan, E., & Lambert, W. C. (2025) · Biology · doi:10.3390/biology14101314 · Cited by 1
Metabolic Landscape and Emerging Therapeutic Potential in Pediatric and Adult Gliomas
Brock, C. S., Nguyen, L., Pattillo, C., Ahamed, C., Sato, K., & Kumar, K. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062720 · Cited by 1
Omene, E. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1849888 · Cited by 1
Gu, X., Zhuang, A., Fan, J., Wen, X., Yang, L., Jia, R., Chai, P., & Fan, X. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101509 · Cited by 1
Metadata
- Authors
- Dunbar, E. M., Coats, B. S., Shroads, A. L., Langaee, T., Lew, A., Forder, J. R., Shuster, J. J., Wagner, D. A., & Stacpoole, P. W.
- Affiliations
- University of Florida Health (US)
- University of Florida (US)
- Metabolic Solutions (US)
- Corresponding author
- Stacpoole, P. W.
- Venue
- Investigational New Drugs
- Published
- 2013-12-03
- Volume
- 32
- Issue
- 3
- Pages
- 452-464
- ISSN
- 0167-6997 (ISSN-L)
- 1573-0646
- PMC
- PMC4455946
- OpenAlex
- W2017529554
- Cited by
- 241
- References
- 50
- Citations by year
- 2026: 30 · 2025: 18 · 2024: 17 · 2023: 15 · 2022: 16 · 2021: 18 · 2020: 18 · 2019: 29 · 2018: 20 · 2017: 17 · 2016: 15 · 2015: 19 · 2014: 9
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Investigational New Drugs (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000064)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- dichloroacetate, glioma, brain metastases, dose-limiting toxicity, drug safety and tolerability, mitochondrial oxidative metabolism
- MeSH terms
- Acetone, Adult, Aged, Alanine Transaminase, Antineoplastic Agents, Aspartate Aminotransferases, Brain Neoplasms, Breath Tests, Dichloroacetic Acid, Female, Glutathione Transferase, Haplotypes, Humans, Male, Maleates, Middle Aged, Pyruvic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
